Literature DB >> 8822991

Increased Monday incidence of life-threatening ventricular arrhythmias. Experience with a third-generation implantable defibrillator.

R W Peters1, S McQuillan, S K Resnick, M R Gold.   

Abstract

BACKGROUND: Examination of the timing of cardiac events provides important pathophysiological information. Previous studies have shown that the onset of acute myocardial infarction occurs most frequently on Monday. The septadian (day of the week) pattern of occurrence of sudden cardiac death and lethal ventricular arrhythmias has not been examined previously. METHODS AND
RESULTS: We examined the septadian distribution of life-threatening (cycle length < 280 ms) ventricular arrhythmias in 683 consecutive patients receiving a Ventak PRx, a third-generation implantable defibrillator with an event recorder. There was a prominent Monday peak, with a midweek decline and a secondary peak later in the week. A marked trough is apparent on both weekend days. The observed pattern was independent of age, sex, ejection fraction, NYHA functional class, type of heart disease, and the use of antiarrhythmic drugs but was not observed in patients receiving beta-blockers.
CONCLUSIONS: Potentially lethal arrhythmias are not random events but occur in a daily pattern suggesting a relationship to the beginning and end of the work week. The absence of a Monday peak in patients receiving beta-blockers suggests that the pattern may be influenced by beta-blockers. This information may be useful in devising strategies to prevent sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822991     DOI: 10.1161/01.cir.94.6.1346

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Hebdomadal rhythms of the heart.

Authors:  C Martyn
Journal:  BMJ       Date:  2000 Dec 23-30

2.  They call it stormy Monday--reasons for referral from primary to secondary care according to the days of the week.

Authors:  A T Vehviläinen; E A Kumpusalo; J K Takala
Journal:  Br J Gen Pract       Date:  1999-11       Impact factor: 5.386

3.  Myocardial infarction rates are higher on weekends than on weekdays in middle aged French men.

Authors:  P Marques-Vidal; D Arveiler; P Amouyel; P Ducimetière; J Ferrières
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

4.  Myocardial integrated ultrasound backscatter in patients with Duchenne's progressive muscular dystrophy.

Authors:  K Mori; T Manabe; M Nii; Y Hayabuchi; Y Kuroda; K Tatara
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 5.  Excess in cardiovascular events on Mondays: a meta-analysis and prospective study.

Authors:  Adrian G Barnett; Annette J Dobson
Journal:  J Epidemiol Community Health       Date:  2005-02       Impact factor: 3.710

Review 6.  Do arrhythmias still deserve our intellectual efforts?: The 2002 Wenckebach Lecture of the Netherlands Society of Cardiology.

Authors:  N M van Hemel
Journal:  Neth Heart J       Date:  2003-08       Impact factor: 2.380

7.  A meta-analysis of excess cardiac mortality on Monday.

Authors:  D R Witte; D E Grobbee; M L Bots; A W Hoes
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

8.  [Circadian variation of ventricular tachyarrhythmias in patients with an implantable cardioverter-defibrillator].

Authors:  C Wolpert; W Jung; S Spehl; T Korte; B Lüderitz
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-03

9.  Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Authors:  Kristen K Patton; Anne S Hellkamp; Kerry L Lee; Daniel B Mark; George W Johnson; Jill Anderson; Gust H Bardy; Jeanne E Poole
Journal:  J Am Coll Cardiol       Date:  2014-04-16       Impact factor: 24.094

Review 10.  Psychobiology of depression/distress in congestive heart failure.

Authors:  Kaki M York; Mustafa Hassan; David S Sheps
Journal:  Heart Fail Rev       Date:  2008-03-27       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.